| Identification | Back Directory | [Name]
6-Deazmino-2'-deoxytubercidine
7-(2-Deoxy--D-ribofuranosyl)-7H-pyrrolo[2,3-d]pyrimidine | [CAS]
93366-89-3 | [Synonyms]
6-Deazmino-2’-deoxytubercidine
7-(2-Deoxy-b-D-ribofuranosyl)-7H-pyrrolo[2,3-d]pyrimidine
7-(2-Deoxy-beta-D-ribofuranosyl)-7H-pyrrolo[2,3-d]pyrimidine
7H-Pyrrolo[2,3-d]pyrimidine, 7-(2-deoxy-β-D-erythro-pentofuranosyl)-
6-Deazmino-2'-deoxytubercidine
7-(2-Deoxy--D-ribofuranosyl)-7H-pyrrolo[2,3-d]pyrimidine
6-Deazmino-2’-deoxytubercidine,7-(2-Deoxy-b-D-ribofuranosyl)-7H-pyrrolo[2,3-d]pyrimidine
6-Deamino-2'-deoxytubercidin, 7-(2-Deoxy-beta-D-ribofuranosyl)-7H-pyrrolo[2,3-d]pyrimidine | [Molecular Formula]
C11H13N3O3 | [MOL File]
93366-89-3.mol | [Molecular Weight]
235.24 |
| Hazard Information | Back Directory | [Uses]
7-(2-Deoxy-β-D-erythro-pentofuranosyl)-7H-pyrrolo[2,3-d]pyrimidine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. | [References]
[1] Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. DOI:10.2174/138161212801227005 |
|
|